Moderna MRNA.O said on Wednesday it had withdrawn the pending application for its flu and COVID combination vaccine candidate for adults aged 50 years and older.
The company would resubmit the application later this year with vaccine efficacy data from the late-stage trial of its experimental seasonal influenza vaccine, it said.